Genertec Universal Medical Group Company Limited, together with its subsidiaries, provides financing, advisory, and medical services in the Mainland China. It operates through two segments, Finance Business and Healthcare Business. The Finance Business segment offers direct finance leasing; sale and leaseback; factoring; operating leases; and advisory services. Its Healthcare Business segment includes medical and healthcare services; hospital operations; import, export, and trading of medical-related goods; equipment life cycle management; medical digitalization services; and intelligent medical health and elder care. The company also provides medical and professional technology, financing, hospital management, medical consulting, sale of medical related goods, medical, software development, and elderly care services. It serves patients, hospitals, medical equipment suppliers, and other public institutions. The company was formerly known as Universal Medical Financial & Technical Advisory Services Company Limited and changed its name to Genertec Universal Medical Group Company Limited in July 2018. The company was founded in 1984 and is headquartered in Beijing, China.
Research context
Genertec Universal Medical Group Company Limited appears in PyInvesting’s Hong Kong Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- HKD
- Sector
- Financial Services
- Industry
- Credit Services
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Genertec Universal Medical Group Company Limited is currently in a long term uptrend where the price is trading 8.2% above its 200 day moving average.
From a valuation standpoint, the stock is 91.9% cheaper than other stocks from the Financial Services sector with a price to sales ratio of 1.2.
Genertec Universal Medical Group Company Limited's total revenue rose by 11.2% to $4B since the same quarter in the previous year.
Its net income has increased by 16.0% to $843M since the same quarter in the previous year.
Finally, its free cash flow fell by 176.1% to $-900M since the same quarter in the previous year.
Based on the above factors, Genertec Universal Medical Group Company Limited gets an overall score of 4/5.